The results showed that the apoptosis rate of glioma cells was higher when radiotherapy was administered at the peak of Per1 or Per2 expression, indicating that clock genes could act as molecular targets that regulate chronotherapy efficacy and promote personalized therapeutic effects. Here, PER1 is linked to glioma.